Blog - Page 1487 of 5721

FridayMar 05, 2021 1:22 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Participation in Upcoming Investor Conferences

Trxade Group (NASDAQ: MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, will be participating in three investor conferences scheduled in March 2021. In all three conferences, Trxade Group CEO Suren Ajjarapu will present valuable information and insights about the company for conference participants. In addition, he is scheduled to participate in one-on-one meetings during each event. Conferences in which Ajjarapu is scheduled to participate include the two-day H.C. Wainwright Global Life Sciences Conference, slated for March 9-10, 2021; the three-day Roth Growth Stock Conference, scheduled for March 15–17, 2021; and the two-day Maxim Group Emerging Growth Conference,…

FridayMar 05, 2021 1:12 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Mediscan Software Offers Convenient, Cost-Effective Imaging Alternative

Healthtech Solutions (OTC: HLTT), through its subsidiary Mediscan Inc., offers a software solution that is far cheaper than CT scans or X-rays and provides quality images for point-of-service medical professionals. “The company’s software specifically transforms ultrasound analog 2D grayscale images into digital 3D HD format that helps technicians derive data-driven insights into the condition of a patient… The software is cloud-based and easy to use anywhere there is an internet connection,” details an article on the innovation. “The Mediscan software application helps ultrasound technicians derive meaningful data-driven clinical evaluations of a patient’s pathology or trauma while facilitating support for treatment…

FridayMar 05, 2021 1:09 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Closing of Acquisition of Primordia Assets

Green Hygienics Holdings (OTCQB: GRYN) today announced that after months of negotiation and diligence, it has closed the acquisition of certain assets of Primordia, a seed-to-soil, single-origin hemp supply company, with a combination of cash and other future rights and entitlements. According to the update, Primordia will continue with its remaining operations under a different name but will not compete with Green Hygienics in this sector. “We are at the forefront of a growing, dynamic new sector within the biotech industry. The demand side continues to grow rapidly, while on the supply side the learning curve is steep and opportunities…

FridayMar 05, 2021 12:58 pm

QualityStocksNewsBreaks – Moleculin Biotech Inc. (NASDAQ: MBRX) Secures $78M in Underwritten Public Offering

Moleculin Biotech (NASDAQ: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, has closed an underwritten public offering of an aggregate of 16,414,736 shares of common stock, including an additional 2,141,052 shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Moleculin secured approximately $78 million in gross proceeds with each of the shares sold at the public offering price of $4.75. Moleculin Biotech intends to use the proceeds to fund its planned clinical trials, preclinical programs, for other research and development activities…

FridayMar 05, 2021 12:52 pm

QualityStocksNewsBreaks – Gage Growth Corp. Announces Expansion of COOKIES Retail Footprint in Michigan

Gage Growth Corp. (d.b.a. Gage Cannabis), a leading high-quality cannabis brand and operator in Michigan, has announced that it will begin serving adult-use consumers at its second COOKIES provisioning center in Kalamazoo starting on Saturday, March 6, 2021. The move comes quickly after the COOKIES location in Kalamazoo opened its doors to serve all patients with a valid Michigan Medical Marijuana ID card in late February. COOKIES, an international cannabis lifestyle brand founded by rapper and entrepreneur Berner, opened its first Michigan location in January 2020. Gage is COOKIES' exclusive partner in Michigan and operates the only COOKIES dispensaries in…

FridayMar 05, 2021 12:35 pm

Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments

Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triage EEG changed clinical management of 76.2% of patients, even when CT or MRI was available Brain Scientific has overcome key barriers causing EEG underuse in emergency medicine Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is making EEGs accessible in emergency departments (“ED”) with cutting-edge tech that bridges the widening gap in access to quality care. As the public becomes more aware of head trauma's long-term effects, triages fill up with potential TBIs and acute neurological conditions. Facilities are scrambling to adapt to…

FridayMar 05, 2021 12:20 pm

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced two funding initiatives that together total an estimated $25 million. The company has entered into securities purchase agreements with institutional and accredited investors (https://ibn.fm/WH4nw) to raise approximately $17.6 million and is involved in a direct offering that is expected…

FridayMar 05, 2021 12:04 pm

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development databases in United States UEC property portfolio includes properties previously explored and developed by senior energy firms UEC has fully licensed, low cost, ISR projects positioned to supply the U.S. Uranium Reserve Nuclear energy included in Democratic Party’s energy platform for first time in 48 years After spending a solid ten years in a downward trend, uranium stocks are now making fresh 52-week highs amid increased demand for energy (https://ibn.fm/GXF7e). Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and…

FridayMar 05, 2021 11:31 am

QualityStocksNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Shifts into Growth Mode with Recent Fundraising, Acquisition Announcements

Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF), a Portland-based cannabis company widely recognized for its Chalice Farms stores and products has raised approximately $8.7 million and recently signed a letter of intent to acquire a store chain in Northwest Oregon, both indications that the company is shifting into a growth mode with a focus on Oregon markets. In a recent article, Golden Leaf Holdings CEO Jeff Yapp noted that the company was waiting to reveal the name of the chain of store pending a definitive purchase agreement. When the deal goes through, Yapp noted, GLH will use monies from…

FridayMar 05, 2021 11:11 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44% CNSP has sublicensed Berubicin to WPD Pharmaceuticals in 31 countries primarily in eastern Europe and western Asia WPD plans to conduct a Phase 2 trial in adults with GBM and a Phase 1 trial for pediatric patients with malignant gliomas CNSP intends to conduct its own Phase 2, potentially pivotal, trial in s…

Site Search

Company Search